Abstract: An apparatus for processing a biological and/or chemical sample in a liquid droplet (1) is provided. The apparatus includes a processing compartment (20), a base (21) and at least one circumferential wall (25). The processing compartment (20) is defined by at least a part of the base (21), at least a part of the circumferential wall (25) and an inlet member (4). The inlet member (4) is located on top of the processing compartment (20), and includes at least one droplet inlet channel (3), which extends through the inlet member (4) and includes a contraction (2) between the inlet opening (28) of the droplet inlet channel (3) to the environment and the outlet opening (27) to the processing compartment (20). There is furthermore provided a method of processing a biological and/or chemical sample in a liquid droplet (1).

Abstract: An electrically non-conductive, nanoparticulate membrane comprising nanoparticles of at least one inorganic oxide of an element selected from Group IA, IIA, IIIA, IVA, IB, IIB, IIIB, IVAB, VB, VIB, VIIB or VIIIB of the Periodic Table, and wherein an oxidoreductase enzyme and a polymeric redox mediator capable of transferring electrons are diffusibly dispersed in said nanoparticulate membrane.

Abstract: The invention provides a process for the preparation of a surface-functionalized nanoparticle comprising: (a) reacting a nanoparticle with a functionalized silane and a base in a substantially non-aqueous solvent to obtain a partially conjugated silanated nanoparticle, wherein the functionalized silane and the base are present in relative amounts such that said functionalized silane undergoes substantially only a single hydrolysis reaction; (b) reacting the partially conjugated silanated nanoparticle formed in step (a) with a base in a solvent in which the partially conjugated silanated nanoparticle is substantially insoluble and in which the base is substantially soluble. The invention also provides a surface-functionalized nanoparticle prepared therefrom and a bioconjugate comprising said a surface-functionalized nanoparticle.

Abstract: One aspect of the present invention relates to mesostructured zeolites. The invention also relates to a method of preparing mesostructured zeolites, as well as using them as cracking catalysts for organic compounds and degradation catalysts for polymers.

Abstract: The present invention relates to methods and apparatuses involving biocompatible structures for tissue engineering and organ replacement and, more specifically, to methods and apparatuses involving biocompatible structures formed by three-dimensional fabrication for tissue engineering and organ replacement. In some embodiments, the biocompatible structures are scaffolds for cells that can be used as tissue engineering templates and/or as artificial organs. The structures may be three-dimensional and can mimic the shapes and dimensions of tissues and/or organs, including the microarchitecture and porosities of the tissues and organs. In some cases, a structure formed by three-dimensional fabrication comprises a wall defining a cavity and a plurality of pores in at least a portion of the wall. The pores may permeate the wall and enable exchange of a component (e.g., a molecule and/or a cell) between a portion interior to the cavity and a portion exterior to the cavity.

Abstract: The present invention relates to articles and methods involving porous materials (e.g., membranes) which may interact with species, such as biological molecules, cells, etc., whereby the species may adhere to or become immobilized with respect to a surface of the porous material or an adhesion layer coating the porous surface. The porous material may be capable of attaching species with control over the positioning and spatial distribution of the species across the surface of the material. Such articles and methods may be useful in, for example, biological assays, biological sensors, or in the culturing of biological cells.

Abstract: The present invention relates to methods for determination of an analyte. The invention provides various methods involving exposure of a luminescent material to an analyte wherein, upon interaction with the analyte, a change in luminescence may be observed as a function of the duration of exposure to electromagnetic radiation, thereby determining the analyte. Some embodiments of the invention include the use of highly emissive semiconductor nanocrystals.

Abstract: The present invention relates to methods and apparatus for manipulating chemical and/or biological species (e.g., cells) and, more specifically, to methods and apparatus for manipulating chemical and/or biological species using magnetic fields. In one embodiment, a method of manipulating cells involves the patterning of cells using a magnetic field modulator, which can modulate the magnetic field created by a magnetic field source. The cells may be magnetically susceptible in some cases; for instance, they may be tagged with magnetic particles. When a fluid containing cells is brought in contact with a surface, and the magnetic field modulator is positioned proximate the surface, the cells may form a pattern proximate the surface by aligning with portions of the modulated magnetic field. The position of the pattern of cells may be at least partially determined by the position of the magnetic field modulator in relation to the surface.

Abstract: The invention relates to materials used as electrodes and/or catalysts, as well as methods associated with the same. The materials may comprise an alloy or intermetallic compound of a transition metal (e.g., Ni) and a metal additive (e.g., Sn). The transition metal and additive are selected to provide improved electrode and/or catalytic performance. For example, the materials of the invention may have a high catalytic activity, while being less susceptible to coking than certain conventional electrode/catalytic materials. These performance advantages can simplify the equipment used in certain applications, as well as reducing energy and capital requirements. Furthermore, the materials may be manufactured using traditional ceramic processing methods, without the need for complex, unconventional fabrication techniques. The materials are particularly suitable for use in fuel cells (e.g., SOFCs electrodes) and in reactions that use or produce synthesis gas.

Abstract: It is provided a Near Infrared Sensitive (NIR-sensitive) nanoparticle complex comprising a NIR-sensitive nanoparticle and surfactant(s) adsorbed on the nanoparticle, wherein the surfactant is at least one surfactant selected from: wherein X=1-9; Y=0-9; n=0-9; Z=1-9; W=0-9; m=0-9; each of R1, R2, R3 and R4, if present, is H, substituted or unsubstituted C1-C6 alkyl, substituted or unsubstituted C1-C6 aryl, HS, COOH, NH2 or OH; R5 is COOH, NH2 or OH; with the proviso that n+m is <10; (b) an amino acid having the structure in (a), wherein X=1; Y=2; Z=1; W=1; R1, R2 and R4 are not present; R3 is NH2; and R5 is COOH; or (c) a peptide, wherein the peptide comprise at least one amino acid (b). Further, it is provided a NIR-sensitive nanoparticle complex(es) having biomolecule(s), for example drug(s), loaded on the surfactant(s).

Abstract: Composites and methods associated with the same are provided. The composite structures are formed of quantum dots and magnetic nanoparticles. The structures may be coated, for example, with a non-organic shell such as silica. In some cases, the shell may be functionalized or derivatized to include compounds, atoms, or materials that can alter or improve properties such as water solubility, water stability, photo-stability and biocompatibility. A reverse microemulsion process can be used to form the coated composites. The composition and other characteristics of the composites may be controlled to provide desired magnetic and optical properties. The structures may be used in a variety of applications including biological labeling, magnetic resonance imagine (MRI) and drug targeting, amongst others.

Abstract: Nanoparticles and methods of making nanoparticles are provided. The nanoparticles may include semiconductor nanocrystals. A shell may encapsulate a nanoparticle core, and the shell may include non-organic material and may be silica. The shell may also include additional species such as PEG. In some embodiments, a passivation layer is in contact with the core.

Abstract: Composite materials comprising a water-soluble compound adsorbed onto a basic inorganic material and a bio-degradable polymer which yields acidic degradation products, methods of producing same, and methods of use thereof are described, wherein the composite materials are designed so as to provide controlled release of the water soluble molecule.

Abstract: Articles and methods for the delivery of drugs and/or nucleic acids. Articles including a nanoparticle are provided that may be used for the delivery of a drug, a nucleic acid, or both, to a subject. The articles may be of polymeric material and may self-assemble.

Abstract: One aspect of the present invention relates to mesostructured zeolites. The invention also relates to a method of preparing mesostructured zeolites, as well as using them as cracking catalysts for organic compounds and degradation catalysts for polymers.

Abstract: Methods for making porous articles are described, along with articles and structures which can be made by these methods. The methods typically involve polymerization of a carbon-containing precursor in the presence of an amphiphilic molecular structure, followed by carbonization to make a final product. Articles of the invention are generally porous, carbon-containing, and can have one or any number of features including crystallinity, electrical conductivity, and porosity of a specific and advantageous nature.

Abstract: The present invention relates to a method of producing particles having a particle size of less than 100 nm and surface areas of at least 20 m2/g where the particles are free from agglomeration. The method involves synthesizing the particles within an emulsion having a 1-40% water content to form reverse micelles. In particular, the particles formed are metal oxide particles. The particles can be used to oxidize hydrocarbons, particularly methane.

Abstract: One aspect of the present invention relates to a catalytic compound of anion-modified metal oxides doped with metal ions. Another aspect of the present invention relates to a method of isomerizing an alkane or alkyl moiety.